MOTS-c 10MG

MOTS-c (Mitochondrial-encoded Open Reading Frame Small C peptide) is a peptide derived from mitochondrial DNA and has garnered significant attention within the research community for its potential implications in metabolic and cellular functions. This product is intended exclusively for research purposes, supporting academic, scientific, or institutional studies in the investigation of its biochemical properties.

Research Context

MOTS-c was first identified in 2013 through screening of open reading frames within the mitochondrial genome. Unlike most mitochondrial peptides, which are typically short and functional within the organelle, MOTS-c has been studied for its ability to exert systemic effects. Initial findings suggested it may influence energy metabolism, insulin sensitivity, and even neuroprotection, though these results remain largely preliminary and require further validation. The peptide’s sequence—comprising 16 amino acids—has sparked curiosity due to its potential to mimic the effects of caloric restriction and exercise, prompting extensive investigation across various scientific disciplines.

Research Overview

MOTS-c has been examined in multiple experimental models, including mice, rats, and cellular cultures, primarily in the context of metabolic syndrome, aging, and neurodegenerative diseases. Early studies indicated that exogenous administration of MOTS-c could enhance mitochondrial function, promote autophagy, and improve glucose tolerance. Subsequent research explored its role in cardiovascular health, where it demonstrated protective effects against ischemia-reperfusion injury. While these findings remain within the preclinical stage, the peptide’s versatility as a potential tool for studying mitochondrial biology and metabolic adaptation continues to be a focal point in scientific exploration.

Key Research Focus Areas

• Metabolic Regulation: Investigation into MOTS-c’s impact on insulin signaling, glucose homeostasis, and lipid metabolism, particularly in relation to mitochondrial function.
• Neuroprotection: Examination of its potential neurogenic and anti-inflammatory effects, including potential roles in Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury models.
• Cardiovascular Health: Analysis of its effects on heart rate variability, endothelial function, and responses to ischemic stress in animal and cell-based studies.
• Aging and Longevity: Exploration of whether MOTS-c contributes to extended lifespan or delayed aging phenotypes in model organisms.
• Immune Modulation: Investigation of its influence on immune cell activity, cytokine production, and inflammatory pathways.

Safety and Handling

While MOTS-c exhibits promising research potential, its long-term effects in vivo remain underexplored, and toxicity studies are limited. As a peptide derived from mitochondrial DNA, MOTS-c is inherently stable and resistant to enzymatic degradation in vitro. However, research institutions must adhere to stringent protocols to ensure proper handling, storage, and administration in accordance with ethical and regulatory standards. All research utilizing MOTS-c must comply with institutional review board (IRB) and biosafety guidelines, particularly for studies involving animal models or human-derived cell lines.

Due to the dynamic nature of scientific research, the findings associated with MOTS-c are subject to ongoing investigation. Consumers and researchers are advised to consult the latest literature and institutional policies before proceeding with studies involving this compound.

For research use only. Not for human or animal consumption.